Filing Flows › AbbVie (ABBV) › Q3 2026
AbbVie (ABBV) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 3, 2026
AbbVie (ABBV) reported revenue of $17.4B for the third quarter 2026 (Q3 2026), +10% from a year earlier and +2% from the quarter before. Operating margin was 36.0%, net earnings $4.2B (24.2% of revenue).
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.4B | +2% | +10% |
| Operating profit | $6.3B | -3% | +229% |
| Net earnings | $4.2B | +17% | 22× |
| Operating cash flow | $7.6B | +121% | +8% |
| Free cash flow | $7.3B | +135% | +10% |
What changed
Revenue was $17.4B in Q3 2026, up 10% year over year and up 2% from the previous quarter.
Operating profit was $6.3B, a 36.0% margin (up 23.9 points year over year). Of the extra revenue versus Q3 2025, 268% reached operating profit, above the 12% margin then. Total costs fell 20% while revenue rose 10%. The fastest-growing cost line was SG&A (+15%). Net earnings were $4.2B, up 2168% year over year. The effective tax rate was 12.6%.
Operating cash flow was $7.6B (up 8% year over year), 180% of net earnings. Non-cash charges added back $1.9B of depreciation and amortization and $0.16B of share-based compensation. Working capital and other items added $1.3B. Capital expenditures of $0.30B left free cash flow of $7.3B.
Questions
What was AbbVie's revenue in the third quarter 2026?
AbbVie (ABBV) reported revenue of $17.4B for the third quarter 2026 (Q3 2026), +10% from a year earlier and +2% from the quarter before.
Was AbbVie profitable in the third quarter 2026?
Operating profit was $6.3B (36.0% of revenue) and net earnings $4.2B.
Source: AbbVie 10-Q on SEC EDGAR.